STAT
JULY 26, 2023
For 15 years, orthopedic surgeon Charles S. Day has been working to highlight the striking lack of diversity in his field, publishing studies showing orthopedics had the fewest Black, Hispanic, and female residents of any surgical specialty. Day himself is Asian American, a group that’s abundant in medicine. But as he dug further, his datasets and personal experiences began to collide.
PharmaVoice
JULY 26, 2023
Perrigo received the first FDA approval for an OTC birth control pill. Now, its global VP of women’s health says the company is working on the next challenge — affordability.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 26, 2023
The new director of the Centers for Disease Control and Prevention, Mandy Cohen, is only two weeks into her new job. But already she hears the clock ticking. If all goes well, Cohen — the successor to Rochelle Walensky, who stepped down at the end of June — will have about 18 months at the helm of the world’s premier public health agency before the next U.S. president is sworn in.
PharmaVoice
JULY 26, 2023
In challenging AbbVie for share of a $19 billion drug market, competitors are testing whether high upfront discounts or behind-the-scenes rebates can win them an advantage.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JULY 26, 2023
Nikki Saltzburg was born three months premature while her parents were vacationing in Bermuda. With Saltzburg weighing just 2 pounds, 2 ounces, they flew her back to Philadelphia on a Navy plane, the whole aircraft set to 98.8 degrees Fahrenheit so that she’d survive the journey. Saltzburg is now a 45-year-old staff psychologist at Florida Atlantic University who has been paralyzed from the waist down almost her whole life.
PharmaVoice
JULY 26, 2023
Over 100 biotech companies so far this year have cut staff due to persistent funding challenges.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
JULY 26, 2023
With many staff across primary care entitled to a pay uplift, The Pharmacist takes a look at how recent pay deals will impact pharmacists working in general practice and Primary Care Networks (PCNs). 6% uplift for salaried practice staff – at employer discretion This month, the Department of Health and Social Care (DHSC) announced a […] The post Are practice-based pharmacists entitled to a pay rise?
STAT
JULY 26, 2023
The country’s largest private psychiatric hospital operator cherry-picks patients whose insurance will pay more, its finance chief said on an earnings call Wednesday. It’s no secret that such hospitals, especially when run by for-profit companies, base admission decisions on how much they’ll get paid, but it’s rare to hear the practice described so bluntly.
The Pharmacist
JULY 26, 2023
Switching more prescription-only medicines (POM) to pharmacy-only medicines (P) could save the NHS £1.4bn a year, according to a new report by Frontier Economics. The report, commissioned by PAGB, the industry body for over-the-counter (OTC) medicines manufacturers, was published this week to mark International Self Care Day, and explores the value of OTC medicines to […] The post More POM to P switches could save NHS £1.4bn a year appeared first on The Pharmacist.
STAT
JULY 26, 2023
WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down the road on some of the more challenging policies. The bill would offer some more transparency into the business practices of pharmacy benefit managers, ensure PBMs aren’t skimming off of the money they send to insurers, prohibit them from overcharging insurers, and ensure certain fees in the Medicare program aren’t tied to a d
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
JULY 26, 2023
The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. One of the FDA’s enforcement mechanisms is the issuance of marketing violation letters to pharmaceutical companies found in violation of advertising and promotion regulations.
STAT
JULY 26, 2023
Last week, Marc Tessier-Lavigne announced that he will resign as president of Stanford over work performed many years ago, in labs at three different institutions. While most of the attention has been focused on the fall from grace of this distinguished scientist, this sad situation carries broader lessons about avoidable outcomes. A delicately worded sentence in the investigative panel’s report notes that there “may have been” opportunities to “improve laboratory ove
PharmExec
JULY 26, 2023
As we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.
STAT
JULY 26, 2023
WASHINGTON — Lawmakers in Congress generally agree that there’s something very broken with the way America pays for prescription drugs. They’re focused this summer on reining in pharmacy middlemen to make the system fairer — but none of their many proposals will actually tackle the core dynamic that has incentivized higher drug prices.
The Pharmacist
JULY 26, 2023
There has been a flurry of media interest in the potential carcinogenicity of the artificial sweetener aspartame in recent weeks. But what is the truth behind the story, and should we be worried? Rod Tucker takes a closer look, in our Review series. Aspartame was produced by James Schlatter, in 1965, while researching anti-ulcer treatments. […] The post Why all the fuss about aspartame?
STAT
JULY 26, 2023
After months of deliberation, the European Commission has agreed to accelerate the phasing out of animal testing, but stopped short of a complete ban — a move that drawing praise from university and industry groups but outrage from animal rights activists. The decision was made in response to a citizen’s initiative , which sought to strengthen an existing ban on animal testing in cosmetics that has been in effect for about a decade.
European Pharmaceutical Review
JULY 26, 2023
The European Commission (EC) has approved Jardiance ® (empagliflozin) for adults with chronic kidney disease (CKD). The oral, once-daily, highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor is the first type 2 diabetes medicine to include cardiovascular death risk reduction data for patients with type 2 diabetes and cardiovascular disease in its label in several countries.
STAT
JULY 26, 2023
Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions. Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release.
Express Pharma
JULY 26, 2023
The product will be manufactured at Lupin’s Pithampur facility in India Lupin has announced that its wholly owned subsidiary in Australia, Generic Health Pty Ltd, has received approval for Tiotropium 18 micrograms powder for inhalation in capsules for use with LupinHaler, its bioequivalent version of SPIRIVA tiotropium (as bromide monohydrate) powder for inhalation from Therapeutic Goods Administration (TGA).
STAT
JULY 26, 2023
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the short person is sleeping in and the official mascots are racing about the sandlot. As for us, we are as busy as ever hunting and gathering items of interest. We trust you have your own hectic agendas. So join us as we hoist the ever-present cup of stimulation and attack the to-do list.
Pharma Times
JULY 26, 2023
The new company’s core mission is to boost patient access to disease-modifying treatments - News - PharmaTimes
STAT
JULY 26, 2023
Stephanie W. Edmonds and Ginny L. Ryan are both doctors. Edmonds, a registered nurse, has a Ph.D.; Ryan is a traditional M.D. But as part of a fight over “scope creep” in health care, many medical doctors might bristle at the idea of calling Edmonds “doctor.” In fact, Florida legislators recently passed a law that would limit who gets to introduce themselves to patients as “doctors.
Express Pharma
JULY 26, 2023
Results are based on analysis of data from 278,375 adults in New Zealand who got the vaccine between April 2018 and July 2021. Most were aged 70 or older Getting vaccinated against shingles could significantly reduce the risk of suffering a stroke or heart attack from the virus, a new study has found. Shingles is caused by the same virus, varicella zoster, that causes chicken pox.
Pharma Times
JULY 26, 2023
The advice includes a national rollout of the HCV GP champion programme and further testing - News - PharmaTimes
BioPharma Dive
JULY 26, 2023
The companies are enrolling people with melanoma in a Phase 3 trial aimed at testing whether the shot can prevent disease recurrence.
World Pharma News
JULY 26, 2023
AbbVie (NYSE: ABBV) and Calibr today announced an expanded strategic collaboration to advance several innovative preclinical and early-stage clinical assets across AbbVie's core therapeutic growth areas including immunology, oncology, neuroscience and other areas of interest. This partnership is an expansion of the collaboration AbbVie and Scripps Research formed in 2019 to develop a broad range of potential new and novel therapeutics.
Pharmaceutical Technology
JULY 26, 2023
Eli Lilly has extended the tender offer expiration date for the acquisition of all Dice Therapeutics in a deal valued at $2.4bn.
Express Pharma
JULY 26, 2023
The Agency had conducted an inspection at Indoco’s manufacturing facility for solid oral dosage form from April 20 – 24, 2023 Indoco Remedies has received EU GMP certification from the Competent Health Authority of Malta for its manufacturing site in Baddi (Unit -I) located at Village Katha, Tehsil- Nalagarh, District– Solan, Himachal Pradesh.
Outsourcing Pharma
JULY 26, 2023
Leslie Orne joined Trinity Life Sciences in 2001 and was recently appointed CEO and president of the fast-growing healthcare consultancy. She previously held the title of chief commercial officer (CCO) and president.
Express Pharma
JULY 26, 2023
Profit After Tax (PAT) for the quarter at Rs 131 crores grew by ~ 13 per cent GlaxoSmithKline Pharmaceuticals (GSK) has declared its financial results for quarter ended June 30, 2023. Revenue from operations for the quarter grew by ~ 1 per cent at Rs 738 crores. The company maintained its gross margins despite the National List of Essential Medicines (NLEM) impact, while EBITDA margins declined ~ 1 per cent on account of new product launch investments led by Shingrix.
Pharmacy Joe
JULY 26, 2023
In this episode, I’ll discuss whether there is an association between the sedative dose and postintubation hypotension and rapid sequence intubation. Episode 838: Hypotension After Intubation - Is It the Sedative Dose That Matters? Subscribe on iTunes , Android , or Stitcher When a patient who requires sedation for intubation also has hemodynamic instability, a common recommendation is to lower the dose of sedative given in hopes of preventing further hemodynamic compromise.
European Pharmaceutical Review
JULY 26, 2023
A Finnish contract development and manufacturing organisation (CDMO) specialising in biopharmaceuticals, has announced it is investing over €50 million to expand its manufacturing facility in Turku, Finland. Biovian’s financing will help to meet the growing demand for innovative biologics and gene therapies. Antti Nieminen, CEO of Biovian, stated that the new manufacturing facility will “contribute to the growth of the biopharmaceutical industry in Finland”.
Pharmaceutical Commerce
JULY 26, 2023
Updated deal will cover exclusive US commercialization for several of Alvotech’s biosimilars.
PharmExec
JULY 26, 2023
Common advice for OA sufferers is joint replacement, but there should be other options.
Commonwealth Pharmacists Association
JULY 26, 2023
The UK teams set off on their voyage to Africa on May 30th 2023, commencing a series of eight inception events that began in Sierra Leone and concluded in
Expert insights. Personalized for you.
246 
Let's personalize your content